NORCROSS, Ga., April 12 /PRNewswire-FirstCall/ -- Immucor, Inc. (Nasdaq: BLUD), a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today announced that it will host its 2010 Institutional Investor and Analyst Day on Wednesday, April 14, 2010 in New York City. The event will begin at 8:30 a.m. (ET) and is expected to conclude at 12:30 p.m. (ET). During the event, Immucor's executive management team will be discussing current developments in the business and growth opportunities for the future.
The live, simultaneous webcast of the event will be available through the "About Us – Investor Relations" section at www.immucor.com.
About Immucor
Founded in 1982, Immucor manufactures and sells a complete line of reagents and systems used by hospitals, reference laboratories and donor centers to detect and identify certain properties of the cell and serum components of blood prior to transfusion. Immucor markets a complete family of automated instrumentation for all of its market segments. For more information on Immucor, please visit our website at www.immucor.com.
SOURCE Immucor, Inc.
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article